RxDoctor Payments Data

Gary Carr, MD

Family Medicine · Lawrenceville, ILNPI 1245264183

Payments from drug & device makers

$1,729in general payments, 2019–2025

Across 97 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$321
  • Lilly USA, LLC$254
  • Novo Nordisk$144
  • AbbVie$132
  • Novartis$103
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$86
  • plus $690 from 22 others

What the payments were for

  • Food & beverage$1,729100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,729 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$8,340
Medicare patients
95
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban257$138,922
JardianceEmpagliflozin152$114,353
XareltoRivaroxaban97$55,371
MounjaroTirzepatide41$42,733
OzempicSemaglutide43$39,594
JanuviaSitagliptin Phosphate31$35,742
NuedextaDextromethorphan Hbr/Quinidine40$30,145
FarxigaDapagliflozin Propanediol36$26,358
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog67$14,479
Potassium Chloride480$13,907
Fiasp FlextouchInsulin Aspart (Niacinamide)23$13,278
TrulicityDulaglutide15$11,861
GlyxambiEmpagliflozin/Linagliptin28$11,312
LinzessLinaclotide11$11,171
Lantus SolostarInsulin Glargine,hum.Rec.Anlog63$9,450

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$28$138,922257 claims
Boehringer IngelheimJardiance, Glyxambi$15$125,665180 claims
Lilly USA, LLCMounjaro, Trulicity$254$54,59456 claims
Novo NordiskOzempic$144$39,59443 claims
MerckJanuvia$14$35,74231 claims
Avanir Pharmaceuticals, Inc.Nuedexta$34$30,14540 claims
AstraZenecaFarxiga, Symbicort$321$29,12948 claims
AbbVieLinzess$132$11,17111 claims
BayerKerendia$45$7,57813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Lawrenceville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →